◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

SUPERNUS PHARMACEUTICALS, INC.

CIK: 1356576 SIC: 2834
$718.95M
Revenue
$-38.55M
Net Income
89.63%
Gross Margin
-8.66%
Op. Margin
$164.62M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 13 of 13 annual reports available (2012 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
+ Total Revenue $718.95M $718.95M $661.82M $607.52M $667.24M $579.77M $520.40M $392.75M $408.90M $302.24M $215.00M $122.05M $12.02M $1.48M
Revenue Growth % 0.0% 8.6% 8.9% -8.9% 15.1% 11.4% 32.5% -3.9% 35.3% 40.6% 76.2% 915.4% 712.1% nan%
Cost of Revenue $74.56M $74.56M $77.91M $83.78M $87.22M $75.06M $52.46M $16.66M $15.36M $15.21M $11.99M $5.76M $1.10M -
+ Gross Profit $644.39M $644.39M $583.91M $523.74M $580.02M $504.71M $467.94M $376.10M $393.54M $287.02M $203.02M $116.29M $10.91M -
Gross Margin % 89.6% 89.6% 88.2% 86.2% 86.9% 87.1% 89.9% 95.8% 96.2% 95.0% 94.4% 95.3% 90.8% nan%
Operating Expenses $781.24M $781.24M $580.15M $612.79M $621.11M $493.75M $346.70M $244.18M $264.45M $202.70M $160.79M $97.81M $73.94M $43.65M
Research & Development $106.23M $106.23M $108.80M $91.59M $74.55M $90.47M $75.96M $69.10M $89.21M $49.58M $42.79M $19.59M $17.25M $23.52M
Selling General & Admin $485.56M $485.56M $321.58M $336.36M $377.22M $304.76M $200.68M $158.43M $159.89M $137.91M $106.01M $72.47M $55.59M $20.13M
+ Operating Income $-62.28M $-62.28M $81.67M $-5.27M $46.12M $86.03M $173.70M $148.57M $144.44M $99.54M $54.22M $24.23M $-61.92M $-42.17M
Operating Margin % -8.7% -8.7% 12.3% -0.9% 6.9% 14.8% 33.4% 37.8% 35.3% 32.9% 25.2% 19.9% -515.2% -2849.3%
Interest Expense - - - $1.32M $2.52M $2.52M $2.52M $2.52M $13.84M $134.00K $543.00K $4.96M $7.85M $3.58M
Interest Income - - - - - - - - $13.84M $2.86M $1.48M $348.00K $299.00K $120.00K
Other Income/Expense $13.25M $13.25M $16.20M $8.04M $14.62M $-12.85M $-5.05M $-1.08M $-4.27M $1.08M $-15.00K $39.00K $101.00K $-660.00K
Income Before Tax $-49.03M $-49.03M $97.87M $2.77M $60.74M $73.17M $168.65M $147.49M $140.18M $100.62M $50.37M $-10.29M $-92.27M $-46.28M
Income Tax Expense $-10.48M $-10.48M $24.00M $1.45M $32.00K $19.75M $41.70M $34.43M $29.18M $43.33M $-40.85M $630.00K - -
+ Net Income $-38.55M $-38.55M $73.86M $1.32M $60.71M $53.42M $126.95M $113.06M $110.99M $57.28M $91.22M $19.87M $-92.27M $-46.28M
Net Margin % -5.4% -5.4% 11.2% 0.2% 9.1% 9.2% 24.4% 28.8% 27.1% 19.0% 42.4% 16.3% -767.7% -3127.3%
Basic EPS -0.68 -0.68 1.34 0.02 1.13 1.01 2.41 2.16 2.13 1.13 1.84 0.47 -2.90 -2.72
Diluted EPS -0.68 -0.68 1.32 0.02 1.04 0.98 2.36 2.10 2.05 1.08 1.76 0.32 -2.90 -2.72
Basic Shares Outstanding - 56.5M 55.1M 54.5M 53.7M 53.1M 52.6M 52.4M 52.0M 50.8M 49.5M 42.3M 31.8M 17.4M
Diluted Shares Outstanding - 56.5M 56.0M 55.5M 61.7M 54.4M 53.7M 53.8M 54.1M 53.3M 51.7M 50.6M 31.8M 17.4M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
Cash & Cash Equivalents $128.45M $69.33M $75.05M $93.12M $203.43M $288.64M $181.38M $192.25M $100.30M $66.40M $36.40M $32.98M $40.30M
Short-term Investments - - $179.82M $368.21M $136.25M $133.89M $165.69M $163.77M $39.74M $23.72M $37.94M $49.21M $48.21M
Accounts Receivable $187.80M $142.08M $144.16M $165.50M $148.93M $140.88M $87.33M $102.92M $65.59M $41.53M $17.27M $5.05M $11.00K
Inventory $112.48M $54.29M $77.41M $91.54M $85.96M $48.33M $26.63M $25.66M $16.30M $16.80M $13.44M $7.15M $1.15M
Other Current Assets $65.33M $36.09M $16.68M $15.78M $27.02M $18.68M $11.61M $8.89M $6.52M $2.96M $3.85M $2.05M $983.00K
Total Current Assets $644.18M $686.07M $493.11M $734.15M $601.59M $630.42M $472.64M $493.49M $228.45M $151.40M $108.89M $97.16M $91.74M
Property Plant & Equipment $10.53M $11.54M $13.53M - - $37.82M $17.07M $4.09M $5.12M $4.34M $2.45M $2.55M $1.42M
Goodwill $124.88M $117.02M $117.02M $117.02M $117.52M $77.91M - - - - - - -
Intangible Assets $569.46M $521.91M $599.89M $702.46M $784.69M $364.34M $24.84M $31.37M $36.02M $16.49M $5.43M $1.16M $683.00K
Long-term Investments - - $16.62M $93.90M $119.17M $350.36M $591.77M $418.80M $133.64M $75.41M $19.82M $8.76M -
Other Non-current Assets $63.80M $31.53M $37.51M $39.81M $49.23M $43.25M $615.00K $380.00K $389.00K $331.00K $918.00K $361.00K $55.00K
Total Assets $1.45B $1.37B $1.28B $1.70B $1.69B $1.50B $1.16B $977.81M $424.46M $309.57M $137.51M $111.00M $93.99M
Accounts Payable $2.68M $4.59M - - - - $10.14M $3.19M $6.84M $8.05M $1.86M $3.14M -
Accrued Liabilities $107.80M $76.35M - - - - - $36.53M $27.30M $27.43M $25.49M $15.17M -
Deferred Revenue - - - - - - - - $287.00K - - - $508.00K
Other Current Liabilities $38.22M - $4.28M $16.86M $20.13M $9.08M $3.24M - - - - - -
Total Current Liabilities $338.17M $292.40M $290.20M $687.96M $315.38M $245.11M $160.59M $161.35M $123.00M $80.74M $27.49M $26.40M $22.98M
Deferred Tax Liabilities - $4.96M $24.96M $49.81M $85.36M $35.22M - - - - - - -
Other Non-current Liabilities $22.19M $7.60M $6.42M $8.69M $16.38M $42.79M $9.41M $11.40M $10.58M $4.00M $3.88M $2.68M $1.51M
Total Liabilities $390.93M $332.34M $356.16M $816.30M $873.30M $759.24M $564.85M $524.79M $156.98M $117.81M $66.15M $77.53M $36.42M
Common Stock $57.00K $56.00K $55.00K $54.00K $53.00K $53.00K $53.00K $52.00K $51.00K $50.00K $43.00K $40.00K $31.00K
Retained Earnings $517.88M $556.43M $482.56M $481.25M $379.92M $326.50M $199.55M $86.49M $-26.82M $-84.29M $-158.66M $-178.53M $-86.25M
Total Stockholders Equity $1.06B $1.04B $921.52M $886.20M $815.85M $744.86M $595.43M $453.02M $267.48M $191.75M $71.35M $33.46M $57.57M
Total Liabilities & Equity $1.45B $1.37B $1.28B $1.70B $1.69B $1.50B $1.16B $977.81M $424.46M $309.57M $137.51M $111.00M $93.99M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
Net Income $-38.55M $-38.55M $73.86M $1.32M $60.71M $53.42M $126.95M $113.06M $110.99M $57.28M $91.22M $19.87M $-92.27M $-46.28M
Depreciation & Amortization $153.69M $91.56M $80.41M $84.86M $85.54M $32.59M $18.14M $6.66M $7.06M $8.13M $2.40M $928.00K $742.00K $871.00K
Stock-based Compensation $56.69M $33.05M $27.75M $26.76M $17.57M $17.91M $16.56M $14.85M $11.29M $8.43M $5.93M $2.72M $1.91M $443.00K
Deferred Income Tax $-9.94M $5.21M $-20.14M $-25.71M $-26.32M $-4.99M $568.00K $-5.83M $-4.17M $21.22M $-41.79M - - -
Change in Receivables $24.62M $22.30M $-2.08M $-18.77M $16.37M $-3.87M $34.61M $-15.75M $35.86M $24.06M $15.62M $12.22M $5.04M $11.00K
Change in Inventory $-6.85M $7.50M $-15.81M $-6.11M $17.86M $14.58M $10.12M $969.00K $9.36M $-497.00K $4.21M $6.29M $6.00M $1.15M
Change in Payables - - - - - - - $6.96M $-3.58M $-620.00K $3.47M $-1.28M $336.00K $318.00K
Operating Cash Flow $167.06M $47.33M $171.95M $111.08M $116.83M $127.13M $138.40M $143.13M $128.99M $114.64M $66.81M $7.73M $-57.95M $-47.20M
Capital Expenditure $2.45M $1.34M $725.00K $551.00K $412.00K - $3.45M $2.74M $844.00K $2.03M $1.60M $593.00K $1.65M $753.00K
Acquisitions - $293.09M - - - $950.00K $298.54M - - - - - - -
Purchases of Investments - - - - - - $95.89M $409.71M $491.65M $101.89M $47.36M $53.26M $85.57M $97.67M
Sales of Investments $1.20B $774.48M $498.87M $370.90M $190.74M - - - - - - - - -
Investing Cash Flow $48.13M $4.11M $-189.87M $268.73M $-216.66M $-81.91M $-34.70M $-157.92M $-413.48M $-86.42M $-35.96M $-4.89M $-12.11M $-48.96M
Stock Issued $44.98M $37.62M $14.91M $6.61M $12.42M $7.09M $4.36M $3.93M $11.58M $5.68M $2.05M $571.00K $2.44M $100.73M
Financing Cash Flow $-32.73M $9.13M $12.19M $-397.88M $-10.48M $-130.42M $3.56M $3.93M $376.44M $5.68M $2.05M $570.00K $62.74M $87.92M
Net Change in Cash $182.46M $60.57M $-5.72M $-18.07M $-110.31M $-85.21M $107.26M $-10.87M $91.94M $33.91M $32.90M $3.42M $-7.32M $-8.24M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $192.10M - $507.38M -
Cost of Revenue $18.96M - $51.55M -
Operating Expenses $252.33M - $565.73M -
Research & Development $29.37M - $78.41M -
Selling General & Admin $179.68M - $363.17M -
Operating Income $-60.23M - $-58.35M -
Other Income/Expense $2.28M - $11.23M -
Income Before Tax $-57.95M - $-47.12M -
Income Tax Expense $-12.84M - $-12.67M -
Net Income $-45.12M $19.92M $-34.45M -
Basic EPS -0.80 - -0.61 -
Diluted EPS -0.80 - -0.61 -
Basic Shares Outstanding $56.55M - $56.13M -
Diluted Shares Outstanding $56.55M - $56.13M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $151.37M $69.33M
Accounts Receivable $171.25M $142.08M
Other Current Assets $62.08M $36.09M
Total Current Assets $593.89M $686.07M
Property Plant & Equipment $10.63M $11.54M
Goodwill $119.08M $117.02M
Intangible Assets $623.48M $521.91M
Other Non-current Assets $62.43M $31.53M
Total Assets $1.42B $1.37B
Other Current Liabilities $26.32M -
Total Current Liabilities $330.63M $292.40M
Deferred Tax Liabilities - $4.96M
Other Non-current Liabilities $7.82M $7.60M
Total Liabilities $370.09M $332.34M
Common Stock $57.00K $56.00K
Retained Earnings $521.98M $556.43M
Total Stockholders Equity $1.05B $1.04B
Total Liabilities & Equity $1.42B $1.37B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-45.12M $19.92M $-34.45M -
Depreciation & Amortization - - $66.55M -
Stock-based Compensation - - $23.40M -
Deferred Income Tax - - $-13.80M -
Change in Receivables - - $5.88M -
Change in Inventory - - $3.32M -
Operating Cash Flow - - $27.47M -
Capital Expenditure - - $911.00K -
Acquisitions - - $293.09M -
Sales of Investments - - $735.16M -
Investing Cash Flow - - $55.42M -
Stock Issued - - $29.06M -
Financing Cash Flow - - $604.00K -
Net Change in Cash - - $83.49M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...